{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T04:35:00Z","timestamp":1715661300482},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,12,27]],"date-time":"2011-12-27T00:00:00Z","timestamp":1324944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00296-011-2270-7","type":"journal-article","created":{"date-parts":[[2011,12,26]],"date-time":"2011-12-26T08:48:31Z","timestamp":1324889311000},"page":"3945-3950","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of efficacy of pamidronate in undifferentiated spondyloarthropathy (uSpA): a placebo control trial in a tertiary level center"],"prefix":"10.1007","volume":"32","author":[{"given":"Rathindra Nath","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibaji","family":"Phaujdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dibyendu","family":"De","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuntal","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,27]]},"reference":[{"key":"2270_CR1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0889-857X(21)00717-1","volume":"18","author":"H Zeidler","year":"1992","unstructured":"Zeidler H, Mau W, Khan MA (1992) Undifferentiated spondyloarthropathies. Rheum Dis Clin N Am 18:187\u2013202","journal-title":"Rheum Dis Clin N Am"},{"key":"2270_CR2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00002281-200107000-00006","volume":"13","author":"I Olivieri","year":"2001","unstructured":"Olivieri I, Salvarini C, Cantini F et al (2001) Ankylosing spondylitis and undifferentiated spondyloarthropathies: a clinical review and description of a disease subset with older age at onset. Curr Opin Rheumatol 13:280\u2013284","journal-title":"Curr Opin Rheumatol"},{"key":"2270_CR3","first-page":"1191","volume-title":"Kelley\u2019s textbook of rheumatology","author":"D Yu","year":"2009","unstructured":"Yu D, McGonagle D, Marzo-Ortega H et al (2009) Undifferentiated spondyloarthritis and reactive arthritis. In: Firestein GS, Budd RC, Harris ED et al (eds) Kelley\u2019s textbook of rheumatology, vol 2, 8th edn. Saunders, Philadelphia, pp 1191\u20131200","edition":"8"},{"key":"2270_CR4","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rheumatology\/kei047","volume":"44","author":"J Zochling","year":"2005","unstructured":"Zochling J, Brandt J, Braun J (2005) The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology (Oxf) 44:1483\u20131491","journal-title":"Rheumatology (Oxf)"},{"key":"2270_CR5","doi-asserted-by":"crossref","first-page":"896","DOI":"10.7326\/0003-4819-136-12-200206180-00011","volume":"136","author":"MA Khan","year":"2002","unstructured":"Khan MA (2002) Update on spondyloarthropathy. Ann Intern Med 136:896\u2013907","journal-title":"Ann Intern Med"},{"key":"2270_CR6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00002281-200107000-00003","volume":"13","author":"RJ Francois","year":"2001","unstructured":"Francois RJ, Braun J, Khan MA (2001) Entheses and enthesitis a histopathological review and relevance to spondyloarthritides. Curr Opin Rheumatol 13:255\u2013264","journal-title":"Curr Opin Rheumatol"},{"key":"2270_CR7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00002281-199807000-00002","volume":"10","author":"SD Khare","year":"1998","unstructured":"Khare SD, Luthra HS, David CS (1998) HLA B27 and other predisposing factors in spondyloarthropathies. Curr Opin Rheumatol 10:282\u2013291","journal-title":"Curr Opin Rheumatol"},{"key":"2270_CR8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00002281-200107000-00004","volume":"13","author":"JD Reveill","year":"2001","unstructured":"Reveill JD, Ball EJ, Khan MA (2001) HLA B27 and genetic predisposing factors in spondyloarthropathies. Curr Opin Rheumatol 13:265\u2013272","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"2270_CR9","first-page":"85","volume":"57","author":"B Amor","year":"1990","unstructured":"Amor B, Dougados M, Mijiyawa M (1990) Criteria of the classification of spondyloarthropathies. Rev Rheum Mal Osteoartic 57(2):85\u201389","journal-title":"Rev Rheum Mal Osteoartic"},{"key":"2270_CR10","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","volume":"34","author":"M Dougados","year":"1991","unstructured":"Dougados M, van der Linden S, Juhlin R et al (1991) The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218\u20131227","journal-title":"Arthritis Rheum"},{"key":"2270_CR11","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/art.1780380407","volume":"38","author":"J Braun","year":"1995","unstructured":"Braun J, Bollow M, Neure L et al (1995) Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 38:499\u2013505","journal-title":"Arthritis Rheum"},{"key":"2270_CR12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/ard.60.4.316","volume":"60","author":"L Lalouxa","year":"2001","unstructured":"Lalouxa L, Voisinb MC, Allainc J et al (2001) Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 60:316\u2013321","journal-title":"Ann Rheum Dis"},{"key":"2270_CR13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/ard.61.6.534","volume":"61","author":"D McGonagle","year":"2002","unstructured":"McGonagle D, Marzo-Ortega H, O\u2019Connor P et al (2002) Histological assessment of the early enthesitis lesion in spondyloarthropathy. Ann Rheum Dis 61:534\u2013537","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2270_CR14","first-page":"246","volume":"22","author":"E Collantes-Estevez","year":"1995","unstructured":"Collantes-Estevez E, Cisnal del Mazo A, Munoz-Gomariz E (1995) Assessment of 2 systems of spondyloarthropathy diagnostic and classification criteria (Amor and ESSG) by a Spanish multicenter study. European spondyloarthropathy study group. J Rheumatol 22(2):246\u2013251","journal-title":"J Rheumatol"},{"key":"2270_CR15","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol 21:2281\u20132285","journal-title":"J Rheumatol"},{"key":"2270_CR16","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson TR, Kennedy LG et al (1994) A new approach to defining disease status in ankylosing spondylitis: the bath AS disease activity index. J Rheumatol 21:2286\u20132291","journal-title":"J Rheumatol"},{"key":"2270_CR17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/rheumatology\/35.1.66","volume":"35","author":"SD Jones","year":"1996","unstructured":"Jones SD, Steiner A, Garrett SL et al (1996) The bath ankylosing spondylitis patient global score (BAS-G). Br J Rheumatol 35:66\u201371","journal-title":"Br J Rheumatol"},{"key":"2270_CR18","first-page":"1694","volume":"21","author":"TR Jenkinson","year":"1994","unstructured":"Jenkinson TR, Mallorie PA, Whitelock HC et al (1994) Defining spinal mobility in ankylosing spondylitis: the bath AS metrology index. J Rheumatol 21:1694\u20131698","journal-title":"J Rheumatol"},{"key":"2270_CR19","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F","volume":"44","author":"JJ Anderson","year":"2001","unstructured":"Anderson JJ, Baron G, van der Heijde D et al (2001) ASAS preliminary criteria for short term improvement in ankylosing spondylitis. Arthritis Rheum 44:1876\u20131886","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2270_CR20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1517\/13543784.15.1.39","volume":"15","author":"C Palazzi","year":"2006","unstructured":"Palazzi C, Padula A, Montaruli M et al (2006) Pharmacological management of undifferentiated spondyloarthropathies. Expert Opin Investig Drugs 15(1):39\u201346","journal-title":"Expert Opin Investig Drugs"},{"key":"2270_CR21","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/0016-5085(93)90667-2","volume":"104","author":"I Bjarnason","year":"1993","unstructured":"Bjarnason I, Hayllar J, MacPherson AJ et al (1993) Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 104:1832\u20131847","journal-title":"Gastroenterology"},{"key":"2270_CR22","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/1529-0131(199911)42:11<2325::AID-ANR10>3.0.CO;2-C","volume":"42","author":"DO Clegg","year":"1999","unstructured":"Clegg DO, Reda DJ, Abdellatif M (1999) Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a department of Veterans affairs cooperative study. Arthritis Rheum 42:2325\u20132329","journal-title":"Arthritis Rheum"},{"key":"2270_CR23","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.1780380507","volume":"38","author":"M Dougados","year":"1995","unstructured":"Dougados M, van der Linden S, Leirisalo-Repo M et al (1995) Sulfasalazine in the treatment of spondylarthropathy: a randomized, multicenter, double-blind, placebo controlled study. Arthritis Rheum 38:618\u2013627","journal-title":"Arthritis Rheum"},{"key":"2270_CR24","first-page":"118","volume":"29","author":"J Brandt","year":"2002","unstructured":"Brandt J, Haibel H, Reddig J et al (2002) Successful short-term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab. J Rheumatol 29:118\u2013122","journal-title":"J Rheumatol"},{"key":"2270_CR25","first-page":"531","volume":"31","author":"J Brandt","year":"2004","unstructured":"Brandt J, Khariouzov A, Listing J et al (2004) Successful short-term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept. J Rheumatol 31:531\u2013538","journal-title":"J Rheumatol"},{"issue":"4","key":"2270_CR26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00002281-200107000-00001","volume":"13","author":"J Braun","year":"2001","unstructured":"Braun J, de Keyser F, Brandt J et al (2001) New treatment option in spondyloarthropathies: increasing evidence for significant efficacy anti-tumor necrosis factor therapy. Curr Opin Rheumatol 13(4):245\u2013249","journal-title":"Curr Opin Rheumatol"},{"key":"2270_CR27","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/art.511","volume":"46","author":"F Bosch Van Den","year":"2002","unstructured":"Van Den Bosch F, Kruithof E, Baeten D et al (2002) Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondyloarthropathy. Arthritis Rheum 46:755\u2013765","journal-title":"Arthritis Rheum"},{"key":"2270_CR28","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","volume":"44","author":"N Mohan","year":"2001","unstructured":"Mohan N, Edwards ET, Cupps TR et al (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritis. Arthritis Rheum 44:2862\u20132869","journal-title":"Arthritis Rheum"},{"key":"2270_CR29","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1023\/A:1016281608773","volume":"12","author":"N Pennanen","year":"1995","unstructured":"Pennanen N, Lapinjoki S, Urtti A et al (1995) Effect of liposomal and free bisphosphonates on the IL-1, IL-6 and TNF-\u03b1 secretion from RAW 264 cells in vitro. Pharm Res 12:916\u2013922","journal-title":"Pharm Res"},{"key":"2270_CR30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/bbrc.1999.1499","volume":"264","author":"E Beek Van","year":"1999","unstructured":"Van Beek E, Pieterman E, Cohen L et al (1999) Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates. Biochem Biophys Res Commun 264:108\u2013111","journal-title":"Biochem Biophys Res Commun"},{"key":"2270_CR31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","volume":"13","author":"SP Luckman","year":"1998","unstructured":"Luckman SP, Hughes DE, Coxon FP et al (1998) Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 13:581\u2013589","journal-title":"J Bone Miner Res"},{"key":"2270_CR32","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/jbmr.5650051005","volume":"5","author":"MG Cecchini","year":"1990","unstructured":"Cecchini MG, Fleisch H (1990) Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage. J Bone Miner Res 5:1019\u20131027","journal-title":"J Bone Miner Res"},{"key":"2270_CR33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02556715","volume":"38","author":"PH Stevenson","year":"1986","unstructured":"Stevenson PH, Stevenson JR (1986) Cytotoxic and migration inhibitory effects of bisphosphonates on macrophages. Calcif Tiss Int 38:227\u2013233","journal-title":"Calcif Tiss Int"},{"key":"2270_CR34","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/jbmr.5650101115","volume":"10","author":"P Sansoni","year":"1995","unstructured":"Sansoni P, Passeri G, Fagnoni F et al (1995) Inhibition of antigen-presenting cell function by Alendronate in vitro. J Bone Miner Res 10:1719\u20131725","journal-title":"J Bone Miner Res"},{"key":"2270_CR35","first-page":"239","volume":"11","author":"MD Francis","year":"1989","unstructured":"Francis MD, Hovancik K, Boyce RW (1989) NE-58095: a diphosphonate, which prevents bone erosion and preserves joint architecture in experimental arthritis. Int J Tiss React 11:239\u2013252","journal-title":"Int J Tiss React"},{"key":"2270_CR36","first-page":"144","volume":"28","author":"WP Maksymowych","year":"2001","unstructured":"Maksymowych WP, Lambert R, Jhangri GS et al (2001) Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. J Rheumatol 28:144\u2013155","journal-title":"J Rheumatol"},{"key":"2270_CR37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jbmr.5650140212","volume":"14","author":"RG Russell","year":"1999","unstructured":"Russell RG, Rogers MJ, Frith JC et al (1999) The pharmacology of bisphosphonates and new insights into their mechanisms of action. J Bone Miner Res 14:53\u201365","journal-title":"J Bone Miner Res"},{"key":"2270_CR38","first-page":"13","volume":"19","author":"JF Offel Van","year":"2001","unstructured":"Van Offel JF, Schuerwegh AJ, Bridts CH et al (2001) Influence of cyclic intravenous pamidronate on proinflammatory monocytic cytokine profiles and bone density in rheumatoid arthritis treated with low dose prednisolone and methotrexate. Clin Exp Rheumatol 19:13\u201320","journal-title":"Clin Exp Rheumatol"},{"key":"2270_CR39","first-page":"2318","volume":"26","author":"FP Cantatore","year":"1999","unstructured":"Cantatore FP, Acquista CA, Pipitone V (1999) Evaluation of bone turnover and osteoclastic cytokines in early rheumatoid arthritis treated with alendronate. J Rheumatol 26:2318\u20132323","journal-title":"J Rheumatol"},{"key":"2270_CR40","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/BF02556671","volume":"41","author":"S Adami","year":"1987","unstructured":"Adami S, Bhalla AK, Dorizzi R et al (1987) The acute phase response after bisphosphonate administration. Calcif Tiss Int 41:326\u2013331","journal-title":"Calcif Tiss Int"},{"key":"2270_CR41","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/jbmr.5650100617","volume":"10","author":"DH Schweitzer","year":"1995","unstructured":"Schweitzer DH, Oostendrop-Van de Ruit M, van der Pluijm G et al (1995) Interleukin-6 and the acute phase response during treatment of patients with Paget\u2019s disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate. J Bone Miner Res 10:956\u2013962","journal-title":"J Bone Miner Res"},{"issue":"Suppl 21","key":"2270_CR42","first-page":"S16","volume":"18","author":"E Toussirot","year":"2000","unstructured":"Toussirot E, Wendling D (2000) Bone mass in ankylosing spondylitis. Clin Exp Rheumatol 18(Suppl 21):S16\u2013S20","journal-title":"Clin Exp Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2270-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-2270-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2270-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T08:56:40Z","timestamp":1640163400000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-2270-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,27]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2270"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-2270-7","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,27]]}}}